Newtown, Pennsylvania — Helius Medical Technologies, Inc. (Nasdaq: HSDT) announced this week that it has added PC’s New England Center for Neurology (“NCNE”) to its Therapeutic Experience Program (TEP). In this company-sponsored, observational, open-label study designed to evaluate the impact of subject adherence to portable neuromodulatory stimulator (PoNS) therapy in patients with multiple sclerosis (MS), NCNE has partnered with other will join his four Centers of Excellence in The initiative will be led by NCNE’s Director of Medical, Dr. Salvatore Napoli.
“Dr. Napoli and his team are important contributors to our PTAP program and we are pleased that they are participating in the TEP study. An acclaimed medical center known for its high-touch, integrated approach to treating disease, said Helius Chief Antonella Favit-Van Pelt, MD, Ph.D. official.
“It is well established that disease progression can be managed by advanced pharmacological and non-pharmacologic therapeutic interventions in many people suffering from the physical symptoms of multiple sclerosis. It has demonstrated the ability to improve gait and balance in patients and we are excited to include this important treatment in our broad range of high quality neurological care,” said Dr. Napoli. .
Follow MyChesCo for all the latest news happening in Chester County and the surrounding area. google news.
Thanks for visiting! Looking for Chester County pride? We’ve got you covered!our shopping MyChesCo store Show your love for Chester County, Pennsylvania. We have shirts, hats, and other products that reflect his unique ChesCo sense. Additionally, the proceeds from each purchase help support our mission of providing trusted information and resources to the people of Chester County.
